Volume 32, No 5, May 2022
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 32 Issue 5, May 2022: 421-422
Lipid nanoparticle-mRNA: another step in the fight against COVID-19
Abhishek Kumar Verma , Stanley Perlman*Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, USA
One of the most important therapies useful in preventing progression of COVID-19 in high-risk patients are monoclonal antibodies targeting the surface glycoprotein. In a recent work in Cell Research, Deng et al. use lipid nanoparticles encapsulating mRNA encoding SARS-CoV-2-specific antibody chains to protect animals from lethal infection.